15 December 2021
The Dorothy Nell Marzol Innovation Grant 2022
Cystic Fibrosis Australia (CFA) is pleased to announce the 2021 Innovation Grant for post- doctoral researchers, currently working in cystic fibrosis (CF) research. This grant is awarded annually to one applicant for one year.
The Innovation Grant will allow a CF researcher to explore novel concepts at the initial feasibility stage. Innovative applications relating to any aspect in the field of CF are encouraged, even those lacking pilot data. The grant aims to allow the researcher to generate sufficient data within the one-year grant period to be in a position to apply for additional support from an appropriate funding body to continue the research.
The Innovation grant will be offered to post-doctoral researchers currently working in or proposing to work in CF research. The researcher will have completed a research higher degree in CF or a related area within the last ten years.
The recipient of the Innovation Grant is required to provide progress reports on their research to CFA every six months. In addition, and where appropriate, the recipient will be asked to make a presentation at a CFA conference (held every two years) in Australia.
The maximum amount awarded under the Innovation Grant will be $80,000. The actual amount provided will be subject to approval of the applicant’s budget.
Applications can be made through the CFA website HERE and must be received no later than 5.00 pm (AEDT) on Friday, 4th February 2022.
The 2022 Innovation Grant is in memory of Dorothy Nell Marzol who was a great supporter of cystic fibrosis research. Her generosity has allowed the Australian Cystic Fibrosis Research Trust to continue their funding of Australian CF researchers in their quest to improve lives for people with CF.